rs1554079284
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM2PP2PP3_StrongPP5_Very_Strong
The NM_000046.5(ARSB):c.1079T>C(p.Leu360Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L360L) has been classified as Likely benign.
Frequency
Consequence
NM_000046.5 missense
Scores
Clinical Significance
Conservation
Publications
- mucopolysaccharidosis type 6Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Genomics England PanelApp, Illumina, Labcorp Genetics (formerly Invitae), G2P, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ARSB | NM_000046.5 | c.1079T>C | p.Leu360Pro | missense_variant | Exon 5 of 8 | ENST00000264914.10 | NP_000037.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ARSB | ENST00000264914.10 | c.1079T>C | p.Leu360Pro | missense_variant | Exon 5 of 8 | 1 | NM_000046.5 | ENSP00000264914.4 | ||
| ARSB | ENST00000396151.7 | c.1079T>C | p.Leu360Pro | missense_variant | Exon 6 of 8 | 1 | ENSP00000379455.3 | |||
| ARSB | ENST00000565165.2 | c.1079T>C | p.Leu360Pro | missense_variant | Exon 5 of 5 | 1 | ENSP00000456339.2 | |||
| ARSB | ENST00000521800.2 | n.261T>C | non_coding_transcript_exon_variant | Exon 2 of 3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Mucopolysaccharidosis type 6 Pathogenic:3
Variant summary: ARSB c.1079T>C (p.Leu360Pro) results in a non-conservative amino acid change located in the sulfatase, N-terminal domain (IPR000917) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251248 control chromosomes (gnomAD). c.1079T>C has been reported in the literature in individuals affected with mild to moderate mucopolysaccharidosis type VI (Maroteaux-Lamy Syndrome) including two homozygous individuals with moderate phenotype (example: Voskoboeva_2022 , Zanetti _2013). These data indicate that the variant is likely to be associated with disease. Leukocyte arylsulfatase B enzyme activity from the homozygous individuals showed reduced enzymatic activity (Zanetti _2013). The following publications have been ascertained in the context of this evaluation (PMID: 23633437, 29620724, 35118118, 24243352). ClinVar contains an entry for this variant (Variation ID: 559672). Based on the evidence outlined above, the variant was classified as pathogenic. -
In vitro functional studies supportive of a damaging effect on the gene product (low to no ARSB activity in homozygotes; PS3); Absent from GnomAD (PM2); Multiple lines of computational evidence support a deleterious effect on the gene product (PP3) -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at